omega-n-methylarginine has been researched along with mozavaptan in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 165 | 8 | 24 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | mozavaptan (IC50) |
---|---|---|---|
Vasopressin V2 receptor | Homo sapiens (human) | 0.6373 | |
Vasopressin V1a receptor | Rattus norvegicus (Norway rat) | 3.2 | |
Vasopressin V1a receptor | Homo sapiens (human) | 1.1373 | |
Vasopressin V1b receptor | Homo sapiens (human) | 2 | |
Vasopressin V1b receptor | Rattus norvegicus (Norway rat) | 5 | |
Vasopressin V2 receptor | Rattus norvegicus (Norway rat) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A | 1 |
1 other study(ies) available for omega-n-methylarginine and mozavaptan
Article | Year |
---|---|
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents | 1997 |